Atrial Appendage Closure Prospective Observational Study (LARIAT)
Status
Conditions
Details and patient eligibility
About
The purpose of this research is to monitor how well patients do after surgery for treatment of left atrial appendage (LAA).
Full description
Patients will be followed in an observational study. We propose to do a single follow-up TEE at 3 to 6 months (this is standard of care) to confirm LAA (left atrial appendage) occlusion. The TEE is not mandatory (this is not a clinical trial), but will be strongly recommended to patients to confirm the efficacy of treatment. This will help confirm whether patients may safely remain off anticoagulation. The risks of TEE are a less than 1 in 1000 risk of death, and a 1% or less risk of a major complication, such as esophageal perforation.
Sex
Ages
Volunteers
Inclusion criteria
- Patients with Atrial fibrillation
- Are poor candidates to take warfarin
- Have elected to undergo a LARIAT procedure
Exclusion criteria
- none
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal